Mcm2 is a marker for chromosomal replication licensing, which is increased in the hippocampus of elderly brains with AD type pathology along with increased expression of Ki67 and Proliferating cell nuclear antigen (PCNA) [177]. Here, PCNA is linked to Alzheimer disease.